Understanding the disease landscape and the competitive clinical trial environment when positioning a new clinical trial within the rare disease space.
Preparing for the Road Ahead: Rare Disease Advocates Unite
Ask the Experts: Why Do Rare Disease Clinical Trials Require a Unique Approach?
According to the National Organization for Rare Disorders (NORD), 90% of rare disorders do not have an FDA-approved treatment. We spoke with Juliane…